These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18555150)

  • 1. Strategies to control massive abdominal bleeding.
    Busani S; Cavazzuti I; Marietta M; Pasetto A; Girardis M
    Transplant Proc; 2008 May; 40(4):1212-5. PubMed ID: 18555150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa as an adjunct in nonoperative management of solid organ injuries in children.
    Vick LR; Islam S
    J Pediatr Surg; 2008 Jan; 43(1):195-8; discussion 198-9. PubMed ID: 18206482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
    Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
    Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant factor VIIA for control of combat-related haemorrhage.
    Woodruff SI; Dougherty AL; Dye JL; Mohrle CR; Galarneau MR
    Emerg Med J; 2010 Feb; 27(2):121-4. PubMed ID: 20156864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of recombinant activated factor VII in trauma patients: Experience from the Australian and New Zealand haemostasis registry.
    Cameron P; Phillips L; Balogh Z; Joseph A; Pearce A; Parr M; Jankelowitz G
    Injury; 2007 Sep; 38(9):1030-8. PubMed ID: 17706654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation management in massive bleeding.
    Griffee MJ; Deloughery TG; Thorborg PA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reappraisal of plasma, prothrombin complex concentrates, and recombinant factor VIIa in patient blood management.
    Goodnough LT
    Crit Care Clin; 2012 Jul; 28(3):413-26, vi-vii. PubMed ID: 22713615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging off-label uses for recombinant activated factor VII: grading the evidence.
    Enomoto TM; Thorborg P
    Crit Care Clin; 2005 Jul; 21(3):611-32. PubMed ID: 15992675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
    Schuster R; Lee SJ; Rink D
    Am Surg; 2003 Nov; 69(11):1017-8. PubMed ID: 14627269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
    Moltzan CJ; Anderson DA; Callum J; Fremes S; Hume H; Mazer CD; Poon MC; Rivard G; Rizoli S; Robinson S
    Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of recombinant activated factor VII in a patient with uncontrolled bleeding from the gastrointestinal tract].
    Vitković R; Petrović I
    Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():246-8. PubMed ID: 19562877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
    Selin S; Tejani A
    Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.